ISIS PHARMACEUTICALS INC's ticker is ISIS and the CUSIP is 464330109. A total of 357 filers reported holding ISIS PHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is 1.83 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $5,584,000 | -29.8% | 138,160 | 0.0% | 0.04% | -22.4% |
| Q2 2015 | $7,951,000 | +180.5% | 138,160 | +210.3% | 0.05% | +172.2% |
| Q1 2015 | $2,835,000 | +542.9% | 44,530 | +523.7% | 0.02% | +500.0% |
| Q4 2014 | $441,000 | -23.6% | 7,140 | -51.9% | 0.00% | -25.0% |
| Q3 2014 | $577,000 | +64.9% | 14,850 | +46.3% | 0.00% | +100.0% |
| Q2 2014 | $350,000 | – | 10,150 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Crosspoint Capital Strategies, LLC | 600 | $37,000 | 0.01% |
| PRENTISS SMITH & CO INC | 200 | $12,000 | 0.01% |
| MARSHALL & SULLIVAN INC /WA/ | 100 | $4,000 | 0.01% |
| MASSMUTUAL TRUST CO FSB/ADV | 0 | $0 | 0.00% |